Skip to content

Preop Cooled Radiofrequency Ablation for Total Knee Replacement

A Pilot Study on the Utility of Cooled Radiofrequency Ablation in Patients Prior to Total Knee Arthroplasty

Status
Withdrawn
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03893292
Enrollment
0
Registered
2019-03-28
Start date
2019-01-24
Completion date
2020-10-30
Last updated
2020-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee Osteoarthritis, Postoperative Pain

Brief summary

Total knee replacement surgery is commonly performed for patients suffering from severe knee osteoarthritis. However, 20% of patients continue to experience pain after surgery. There is currently no standardized pain management protocol for pain after total knee replacement. Cooled radiofrequency ablation has been used successfully to alleviate spin-related pain and has recently been approved by the FDA to treat chronic knee arthritic pain. This pilot study aims to collect preliminary data on the use of cooled radiofrequency ablation in patients undergoing total knee replacement.

Detailed description

The number of patients who undergo total knee replacement is rising significantly. However, many of these patients are dissatisfied with the results, because they continue to experience pain postoperatively. This pain can be debilitating and can also be associated with decreased quality of life. Given the increasing number of patients undergoing total knee replacement and a dissatisfaction rate of 8-44%, improvements must be made in pain management protocols to help decrease pain in the immediate postoperative period following total knee replacement. Cooled radiofrequency ablation is a procedure that uses water-cooled technology to denervate the sensory nerves. It is widely used in the spine and is increasingly being used in the knee to treat osteoarthritis. Existing studies have shown that it can significantly reduce pain in patients with chronic osteoarthritis. In terms of its potential benefit as a preoperative measure to minimize postoperative pain, the literature is sparse. Results from this study will be used to generate hypotheses and power for future studies.

Interventions

PROCEDURETotal knee replacement

Patients will undergo total knee replacement surgery.

DEVICECOOLIEF

The superior lateral genicular nerve, superior medial genicular nerve, and inferior medial geniculate nerve will be ablated.

Sponsors

Hospital for Special Surgery, New York
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients undergoing unilateral primary total knee replacement for osteoarthritis * Pain \>6 (on a scale of 0-10) * Body mass index: 21-35 kg/m2

Exclusion criteria

* Age \<65 years * Patients who are wheelchair bound * History of inflammatory arthritis or rheumatic disease * Body mass index \<21 or \>35 kg/m2 * Chronic opioid use * Pregnant women * Non-English speaking

Design outcomes

Primary

MeasureTime frameDescription
PainUp to 1 year post-total knee replacementPain will be assessing on a 0-10 scale, where 0=no pain and 10=most pain.

Secondary

MeasureTime frameDescription
Knee DisabilityUp to 1 year post-total knee replacementKnee disability will be assessed using the Knee Injury and Osteoarthritis Outcome Score for Joint Replacement (KOOS JR). The score ranges from 0-100, where 0=total knee disability and 10=perfect health.
Function assessed using the PROMIS-physical function computer adaptive testUp to 1 year post-total knee replacementFunction will be assessed using the PROMIS-physical function computer adaptive test. A higher score indicates higher function.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026